{"id":"W2112626326","doi":"10.3109/10428194.2013.858154","title":"The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma","year":2013,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prednisone; Vincristine; Cyclophosphamide; Medicine; Doxorubicin; Peripheral; Lymphoma; Peripheral T-cell lymphoma; Chemotherapy; Oncology; Internal medicine; Immunology; T cell; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006391817,0.0003984882,0.0004697234,0.0004840507,0.001044131,0.0008375954,0.0004096288,0.003608619,0.003661882],"category_scores_gemma":[0.002886395,0.0002383005,0.0005937769,0.0005880648,0.0009186981,0.0008920659,0.0003402209,0.004177544,0.003103229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001396359,"about_ca_system_score_gemma":0.0006614279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009848891,"about_ca_topic_score_gemma":0.003683595,"domain_scores_codex":[0.9992867,0.0002581342,0.00009781378,0.0001100309,0.0001659492,0.00008144318],"domain_scores_gemma":[0.9990368,0.000480967,0.0001173038,0.00006019847,0.0001402144,0.0001645475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005440062,0.0004960558,0.04823872,0.00105236,0.0001791355,0.2309912,0.0005511629,0.001368611,0.005953305,0.00601829,0.4458733,0.2587338],"study_design_scores_gemma":[0.0002969127,0.0005384131,0.02673674,0.0006429526,0.00008419523,0.5499943,0.0004505907,0.001928249,0.00139849,0.01056446,0.4073168,0.00004787729],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.09032921,0.03962808,0.003116607,0.7782701,0.01466426,0.0001782339,0.0001993893,0.0001703962,0.0734437],"genre_scores_gemma":[0.463461,0.02976209,0.00424437,0.3743156,0.09363946,0.0001789474,0.0001848478,0.00006870861,0.03414498],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.003661882,"threshold_uncertainty_score":0.01225019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008534077756637998,"score_gpt":0.2187802231035999,"score_spread":0.2102461453469619,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}